Evidence map›Paper›PMID 36376357›Full record

ArticleScientific reports2022

A new negative feedback mechanism for MAPK pathway inactivation through Srk1 MAPKAP kinase.

Maribel Marquina, Eva Lambea, Mercé Carmona, Marta Sánchez-Marinas, Sandra López-Aviles, José Ayte, Elena Hidalgo, Rosa Aligue

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maribel Marquina *Department of Biomedical Science, University of Barcelona, CIBERonc, Barcelona, Spain.
Eva Lambea *Department of Biomedical Science, University of Barcelona, CIBERonc, Barcelona, Spain.
Mercé CarmonaOxidative Stress and Cell Cycle Group, Universitat Pompeu Fabra, Barcelona, Spain.
Marta Sánchez-MarinasDepartment of Biomedical Science, University of Barcelona, CIBERonc, Barcelona, Spain.
Sandra López-AvilesDepartment of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.
José AyteOxidative Stress and Cell Cycle Group, Universitat Pompeu Fabra, Barcelona, Spain.
Elena HidalgoOxidative Stress and Cell Cycle Group, Universitat Pompeu Fabra, Barcelona, Spain.
Rosa AligueDepartment of Biomedical Science, University of Barcelona, CIBERonc, Barcelona, Spain. aliguerosa@ub.edu.

Funding

Generalitat de Catalunya SRG201 7-00037Ministerio de Ciencia y Tecnología BFU2015-65311-R
6 · The paper itself

Abstract

The fission yeast mitogen-activated kinase (MAPK) Sty1 is essential for cell survival in response to different environmental insults. In unstimulated cells, Sty1 forms an inactive ternary cytoplasmatic complex with the MAPKK Wis1 and the MAPKAP kinase Srk1. Wis1 phosphorylates and activates Sty1, inducing the nuclear translocation of the complex. Once in the nucleus, Sty1 phosphorylates and activates Srk1, which in turns inhibits Cdc25 and cell cycle progression, before being degraded in a proteasome-dependent manner. In parallel, active nuclear Sty1 activates the transcription factor Atf1, which results in the expression of stress response genes including pyp2 (a MAPK phosphatase) and srk1. Despite its essentiality in response to stress, persistent activation of the MAPK pathway can be deleterious and induces cell death. Thus, timely pathway inactivation is essential to ensure an appropriate response and cell viability. Here, uncover a role for the MAPKAP kinase Srk1 as an essential component of a negative feedback loop regulating the Sty1 pathway through phosphorylation and inhibition of the Wis1 MAPKK. This feedback regulation by a downstream kinase in the pathway highlights an additional mechanism for fine-tuning of MAPK signaling. Thus, our results indicate that Srk1 not only facilitates the adaptation to stress conditions by preventing cell cycle progression, but also plays an instrumental role regulating the upstream kinases in the stress MAPK pathway.

Indexed as

SchizosaccharomycesSchizosaccharomyces pombe ProteinsFeedbackGene Expression Regulation, FungalMitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesMitogensPhosphorylationMitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesMitogensSchizosaccharomyces pombe ProteinsSRK1 protein, S pombewis1 protein, S pombe

Identifiers

PMID36376357
PMCPMC9663701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.